Please check your internet connection and try again.
# Ecospirin 75mg Enteric-Coated
## Overview
Ecospirin is a brand name for aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with antiplatelet, analgesic, and antipyretic properties. This formulation is enteric-coated to reduce gastrointestinal irritation.
## Primary Indications
* Secondary prevention of cardiovascular events (e.g., myocardial infarction, stroke) in patients with established cardiovascular disease.
* Prevention of thromboembolic events in patients at risk.
## Adult Dosing
* **Cardiovascular Prevention:** 75 mg to 150 mg orally once daily. Dosing is often guided by local protocols and patient-specific risk factors.
## Pediatric Dosing
* Aspirin use in children and adolescents is generally discouraged due to the risk of Reye's syndrome, particularly during viral illnesses. Specific indications and dosing in pediatric populations are not established for this indication and should only be considered under strict medical supervision by a specialist.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment for low-dose aspirin used for cardiovascular prevention, but caution is advised in severe impairment.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Active peptic ulcer disease.
* History of gastrointestinal bleeding or perforation.
* Severe hepatic or renal impairment.
* Severe heart failure.
* Bleeding disorders (e.g., hemophilia).
* Concomitant use with methotrexate (especially in high doses).
* Children and adolescents with viral infections (risk of Reye's syndrome).
## Adverse Effects
* **Common:** Gastrointestinal upset (dyspepsia, nausea, vomiting), heartburn, abdominal pain.
* **Serious:** Gastrointestinal bleeding, occult blood loss, perforation, tinnitus, hearing loss, bronchospasm (especially in aspirin-sensitive asthma), urticaria, angioedema, anaphylaxis, Reye's syndrome (in children/adolescents), renal impairment, liver dysfunction.
## Key Drug Interactions
* **Increased bleeding risk:** Anticoagulants (e.g., warfarin, heparin, DOACs), other antiplatelet agents (e.g., clopidogrel, ticagrelor), SNRIs, SSRIs, corticosteroids, NSAIDs.
* **Methotrexate:** Increased methotrexate toxicity (especially at high-dose aspirin).
* **Valproic acid:** Increased valproic acid levels.
* **Uricosuric agents:** Decreased efficacy of probenecid, sulfinpyrazone.
* **Antihypertensives:** May reduce the effectiveness of some antihypertensive medications.
* **Alcohol:** Increased risk of gastrointestinal bleeding.
## Monitoring
* Monitor for signs and symptoms of gastrointestinal bleeding (melena, hematochezia, abdominal pain, vomiting blood).
* Monitor for tinnitus or hearing changes, which may indicate salicylate toxicity.
* Periodic renal and liver function tests may be considered, especially in patients with risk factors.
## Clinical Pearls
* The enteric coating is designed to prevent dissolution in the stomach and dissolution in the small intestine, which may delay absorption. Do not crush or chew enteric-coated aspirin.
* For urgent situations requiring immediate antiplatelet effect, non-enteric-coated aspirin may be preferred.
* The benefit of low-dose aspirin for cardiovascular prevention must be weighed against the risk of bleeding.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before making clinical decisions.
